Patents by Inventor Kyohei Takahashi
Kyohei Takahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240142375Abstract: A sample observation device includes a light source unit configured to output a pulse train in which multiple optical pulses with different center wavelengths are arranged at predetermined time intervals as excitation light; a measurement unit configured to perform time-resolved measurement on an optical response that is transmitted from the sample and corresponds to irradiation with the optical pulses included in the pulse train while scanning the sample with the excitation light, and to acquire measurement data with respect to the optical pulses; and a processing unit configured to perform linear unmixing processing on the measurement data with respect to the optical pulses on the basis of an excitation spectrum for every target included in the sample.Type: ApplicationFiled: December 15, 2021Publication date: May 2, 2024Applicant: HAMAMATSU PHOTONICS K.K.Inventors: Kyohei SHIGEMATSU, Koji TAKAHASHI, Takashi INOUE
-
Patent number: 11968332Abstract: There is provided with an information processing apparatus. A first obtaining unit obtains data of a reference image indicating a target of printing output to be performed by a printing apparatus. A second obtaining unit obtains data of an image printed by the printing apparatus. A correcting unit corrects a local image density difference or the reference image based on a global image density difference between the reference image and the printed image. An evaluating unit evaluates quality of the printed image based on the local image density difference between the corrected reference image and the printed image.Type: GrantFiled: June 9, 2022Date of Patent: April 23, 2024Assignee: CANON KABUSHIKI KAISHAInventors: Kyohei Kikuta, Kosei Takahashi
-
Publication number: 20240116004Abstract: A blood treatment material has both the water permeability to allow removal of water from the blood and the ability to highly efficiently adsorb and remove, for example, inflammatory cells and inflammatory cytokines. The blood treatment material includes a hollow fiber membrane having a surface modified with a ligand containing an amino group(s), wherein the arithmetic mean roughness (RaA) of the blood-contacting surface of the hollow fiber membrane in the radial direction calculated by using a laser microscope is 0.10 ?m to 0.80 ?m.Type: ApplicationFiled: April 15, 2022Publication date: April 11, 2024Applicant: Toray Industries, Inc.Inventors: Kyohei Yamashita, Hiroshi Takahashi
-
Publication number: 20240110833Abstract: A dispersion measurement apparatus includes a pulse forming unit, a correlation optical system, a beam splitter, an operation unit, an imaging unit, a spatial filter unit, and a photodetector. The pulse forming unit forms a light pulse train including light pulses having time differences and different center wavelengths. The beam splitter branches the light pulse train passed through a measurement object. The imaging unit disperses one light pulse train and images each light pulse. The spatial filter unit extracts light of a partial region of the other light pulse train. The correlation optical system outputs correlation light including a cross-correlation or an autocorrelation of the extracted light. The photodetector detects a temporal waveform of the correlation light. The operation unit estimates a wavelength dispersion amount in the measurement object based on a feature value of the temporal waveform.Type: ApplicationFiled: December 6, 2023Publication date: April 4, 2024Applicant: HAMAMATSU PHOTONICS K.K.Inventors: Koyo WATANABE, Hisanari TAKAHASHI, Kyohei SHIGEMATSU, Takashi INOUE
-
Publication number: 20240071659Abstract: A metal magnetic powder includes: metal nanoparticles having an average particle size (D50) is 1 nm to 100 nm, and a main phase of hcp-Co; and an additive elements ? including at least one of Fe, Ni, and Cu.Type: ApplicationFiled: August 25, 2023Publication date: February 29, 2024Applicant: TDK CORPORATIONInventors: Isao KANADA, Hiroshi ITO, Kyohei TAKAHASHI
-
Publication number: 20240071662Abstract: The metal magnetic powder includes Co as a main component, and an average particle size (D50) of 1 nm to 100 nm. An X-ray diffraction chart of the metal magnetic powder has a first peak that appears in a range of a diffraction angle 2? of 41.6±0.3°, and a second peak that appears in a range of a diffraction angle 20? of 47.4±0.3°. When a full width at half maximum of the first peak is set as FW1, and a full width at half maximum of the second peak is set as FW2, a ratio (FW2/FW1) of FW2 to FW1 is 1 to 5.Type: ApplicationFiled: August 25, 2023Publication date: February 29, 2024Applicant: TDK CORPORATIONInventors: Kyohei TAKAHASHI, Hiroshi ITO, Isao KANADA
-
Patent number: 11913836Abstract: A dispersion measurement apparatus includes a pulse forming unit, a correlation optical system, a beam splitter, an operation unit, an imaging unit, a spatial filter unit, and a photodetector. The pulse forming unit forms a light pulse train including light pulses having time differences and different center wavelengths. The beam splitter branches the light pulse train passed through a measurement object. The imaging unit disperses one light pulse train and images each light pulse. The spatial filter unit extracts light of a partial region of the other light pulse train. The correlation optical system outputs correlation light including a cross-correlation or an autocorrelation of the extracted light. The photodetector detects a temporal waveform of the correlation light. The operation unit estimates a wavelength dispersion amount in the measurement object based on a feature value of the temporal waveform.Type: GrantFiled: September 29, 2021Date of Patent: February 27, 2024Assignee: HAMAMATSU PHOTONICS K.K.Inventors: Koyo Watanabe, Hisanari Takahashi, Kyohei Shigematsu, Takashi Inoue
-
Publication number: 20230339018Abstract: A metal magnetic powder includes Co as a main component, and the metal magnetic powder includes metal nanoparticles having a mean particle size (D50) of 1 nm or more and 100 nm or less. Each of the metal nanoparticles includes hcp-Co as a main phase, and the metal magnetic powder includes at least one amphoteric metal.Type: ApplicationFiled: April 18, 2023Publication date: October 26, 2023Applicant: TDK CORPORATIONInventors: Kyohei TAKAHASHI, Hiroshi ITO, Isao KANADA, Akito HASEGAWA
-
Publication number: 20230343497Abstract: A metal magnetic powder contains Co as a main component, and the metal magnetic powder includes metal nanoparticles having a mean particle size (D50) of 1 nm or more and 100 nm or less. Each of the metal nanoparticles includes hcp-Co as a main phase, and the metal magnetic powder includes fcc-Co and/or ?-Co as a sub-phase.Type: ApplicationFiled: April 18, 2023Publication date: October 26, 2023Applicant: TDK CORPORATIONInventors: Kyohei TAKAHASHI, Hiroshi ITO, Isao KANADA, Kazuhiro YOSHIDOME
-
Patent number: 11439652Abstract: An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or at least two isotonic agents. The ophthalmic aqueous composition is substantially free of sodium chloride. This ophthalmic aqueous composition is excellent in drug stability and drug migration and has a clear appearance.Type: GrantFiled: July 24, 2020Date of Patent: September 13, 2022Assignees: SANTEN PHARMACEUTICAL CO., LTD., DAIICHI SANYO COMPANY, LIMITEDInventors: Yoko Endo, Kyohei Takahashi, Shinya Umezaki
-
Patent number: 11424059Abstract: The present invention provides a composite magnetic body comprising metal particles containing Fe or Fe and Co as a main component, a resin, and voids, wherein an average major axis diameter of the metal particles is 30 to 500 nm, an average aspect ratio of the metal particles is 1.5 to 10, and in a cross section of the composite magnetic body, a percent presence of the voids is 0.2 to 10 area % and an average equivalent circle diameter of the voids is 1 ?m or less, and a saturation magnetization of the composite magnetic body is 300 to 600 emu/cm3.Type: GrantFiled: March 21, 2019Date of Patent: August 23, 2022Assignee: TDK CorporationInventors: Kyohei Takahashi, Isao Kanada
-
Publication number: 20220135341Abstract: A position switching device includes a rotating body, a drive unit, and a plurality of position switching rods. The rotating body has, on a surface, a plurality of position switching groove groups each defining a plurality of switching positions and rotates about one shaft as a rotation axis. The drive unit rotationally drives the rotating body in a first rotation direction or a second rotation direction opposite to the first rotation direction. The plurality of position switching rods each has one end engaged with corresponding one of the plurality of the position switching groove groups and the other end engaged with corresponding one of a plurality of position switching mechanisms.Type: ApplicationFiled: January 13, 2022Publication date: May 5, 2022Inventors: Kyohei TAKAHASHI, Daigo ARAKIDA
-
Publication number: 20210267885Abstract: Disclosed herein is an aqueous composition comprising 0.001-0.1% (w/v) atropine or a salt thereof, a water-soluble polymer, and buffer (I), which is at a pH range of 6 or lower, wherein the buffer (I) is at least one selected from the group consisting of a phosphate buffer, an aminocarboxylate buffer, a carbonate buffer, an acetate buffer, a tartrate buffer, a borate buffer, and trometamol.Type: ApplicationFiled: May 24, 2017Publication date: September 2, 2021Inventors: Donald TAN, Roger BEUERMAN, Hiroyuki ASADA, Kyohei TAKAHASHI, Koji SAKANAKA, Takashi MORIMOTO, Toyomi FUJISAWA
-
Publication number: 20210000844Abstract: Provided is an ophthalmic composition comprising diquafosol or a salt thereof and a cationic polymer, the cationic polymer being at least one selected from the group consisting of chitosan, a chitosan derivative, a cationic (meth)acrylate copolymer, a cationic silicone polymer, a diallyl quaternary ammonium salt-acrylamide copolymer, cationic hydrolyzed keratin, cationic hydrolyzed silk, cationic hydrolyzed collagen, cationic hydrolyzed casein, cationic hydrolyzed soy protein, a cationic vinylpyrrolidone copolymer, polyvinylpyrrolidone, a dimethyldiacrylammonium chloride homopolymer, an adipic acid-dimethylaminohydroxypropyldiethylenetriamine copolymer, an adipic acid-epoxypropyldiethylenetriamine copolymer and an acrylamide-?-methacryloyloxyethyltrimethylammoniummethyl sulfate copolymer.Type: ApplicationFiled: February 27, 2019Publication date: January 7, 2021Applicant: Santen Pharmaceutical Co., Ltd.Inventors: Kyohei TAKAHASHI, Hiroyuki ASADA, Asuka KAMIMURA, Kenji MORISHIMA, Yusuke MOMOKAWA, Kenichi ENDO
-
Patent number: 10854376Abstract: A coil component includes a coil and a composite magnetic material containing magnetic particles. The magnetic particles have an average minor-axis length of more than 5.0 nm and 50 nm or less and an average aspect ratio of 2.0 or more and 10.0 or less. The magnetic particles are orientated substantially perpendicularly to a central axis of the coil and are orientated randomly within a perpendicular plane to the central axis of the coil. The composite magnetic material has a saturation magnetization ?s of 80.0 emu/g or more.Type: GrantFiled: June 20, 2018Date of Patent: December 1, 2020Assignee: TDK CORPORATIONInventors: Akihiro Harada, Yoshihiro Shinkai, Kyohei Takahashi, Tomoya Hanai
-
Publication number: 20200352964Abstract: An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or at least two isotonic agents. The ophthalmic aqueous composition is substantially free of sodium chloride. This ophthalmic aqueous composition is excellent in drug stability and drug migration and has a clear appearance.Type: ApplicationFiled: July 24, 2020Publication date: November 12, 2020Applicants: SANTEN PHARMACEUTICAL CO., LTD., DAIICHI SANKYO COMPANY, LIMITEDInventors: Yoko ENDO, Kyohei TAKAHASHI, Shinya UMEZAKI
-
Patent number: 10758554Abstract: An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or at least two isotonic agents. The ophthalmic aqueous composition is substantially free of sodium chloride. This ophthalmic aqueous composition is excellent in drug stability and drug migration and has a clear appearance.Type: GrantFiled: November 5, 2015Date of Patent: September 1, 2020Assignees: SANTEN PHARMACEUTICAL CO., LTD., DAIICHI SANKYO COMPANY, LIMITEDInventors: Yoko Endo, Kyohei Takahashi, Shinya Umezaki
-
Publication number: 20190304648Abstract: The present invention provides a composite magnetic body comprising metal particles containing Fe or Fe and Co as a main component, a resin, and voids, wherein an average major axis diameter of the metal particles is 30 to 500 nm, an average aspect ratio of the metal particles is 1.5 to 10, and in a cross section of the composite magnetic body, a percent presence of the voids is 0.2 to 10 area % and an average equivalent circle diameter of the voids is 1 ?m or less, and a saturation magnetization of the composite magnetic body is 300 to 600 emu/cm3.Type: ApplicationFiled: March 21, 2019Publication date: October 3, 2019Applicant: TDK CorporationInventors: Kyohei TAKAHASHI, Isao KANADA
-
Patent number: 10422354Abstract: A hydraulic accumulator includes a limiting portion that is fitted into a ring end gap of a snap ring to limit a decrease in a diameter of the snap ring. The snap ring is stamped from a metal sheet by a press machine. Therefore, one of two opposed surfaces of a portion of the snap ring, which is fitted into a groove, forms a sloped surface as a result of shear droop. The limiting portion is fitted into the ring end gap of the snap ring to limit the decrease in the diameter of the snap ring. Thus, it is possible to limit riding of the sloped surface of the snap ring on a corner of the groove, and thereby it is possible to limit removal of the snap ring from the groove.Type: GrantFiled: March 8, 2018Date of Patent: September 24, 2019Assignees: DENSO CORPORATION, HONDA MOTOR CO., LTD.Inventors: Kyohei Takahashi, Tatsuya Kitanaka, Itsuki Shimazaki, Shunsuke Yoshida, Yoshiatsu Asai
-
Publication number: 20190006095Abstract: A coil component includes a coil and a composite magnetic material containing magnetic particles. The magnetic particles have an average minor-axis length of more than 5.0 nm and 50 nm or less and an average aspect ratio of 2.0 or more and 10.0 or less. The magnetic particles are orientated substantially perpendicularly to a central axis of the coil and are orientated randomly within a perpendicular plane to the central axis of the coil. The composite magnetic material has a saturation magnetization ?s of 80.0 emu/g or more.Type: ApplicationFiled: June 20, 2018Publication date: January 3, 2019Applicant: TDK CORPORATIONInventors: Akihiro HARADA, Yoshihiro SHINKAI, Kyohei TAKAHASHI, Tomoya HANAI